scholarly journals Ultrasound Diagnosis of Congestion in the Pulmonary and Systemic Circulations in Patients with Atrial Fibrillation and Chronic Heart Failure

2021 ◽  
Author(s):  
Venera Kirillova ◽  
Andrey Smorgon ◽  
Alla Garganeeva ◽  
Roman Batalov ◽  
Viktor Meshchaninov ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Chronic Heart Failure ◽  
Inferior Vena Cava ◽  
Pulmonary Vein ◽  
Inferior Vena ◽  
Vena Cava ◽  
Average Pressure ◽  
Superior Pulmonary Vein ◽  
The Right

Abstract BackgroundFluid retention is one of the most common reasons for the heart failure decompensation. The purpose of the study is to estimate the sensitivity, specificity of the ultrasound method for evaluating congestive phenomena in the systemic and pulmonary circulations in patients with the atrial fibrillation (AF) and chronic heart failure (CHF).MethodsThe study includes 28 patients with the paroxysmal AF with and without CHF, who were planned for the radiofrequency pulmonary veins isolation. The maximum and minimum diameters of the right superior pulmonary vein and inferior vena cava on exhalation were measured echocardiographically. An average pressure in the right and left atria was measured intraoperatively. Сorrelation between the maximum and minimum diameters of the right superior pulmonary vein and an average pressure in the left atria and between inferior vena cava on exhalation and an average pressure in the right atria was calculated. The sensitivity, specificity of ultrasound methods for evaluating congestive phenomena in the systemic and pulmonary circulations was evaluated.ResultsThere was positive correlation between the minimum diameter of right superior pulmonary vein and invasive mean pressure in the left atrium (R=0.65, P<0.05), between invasive measured mean pressure in the right atrium and the diameter of the inferior vena cava on exhalation (R=0.49, P<0.05). Sensitivity of the method – maximum diameters of the right superior pulmonary vein greater than 21.7 mm are ultrasound criteria for venous pulmonary hypertension is 75%, specificity – 86%. Sensitivity of the method minimum diameters of the right superior pulmonary vein greater than 10.5 mm are ultrasound criteria for venous pulmonary hypertension is 85%, specificity – 86%. The sensitivity of the inferior vena cava diameter exceeding 18,5 mm on exhalation is 100%, the specificity is 92%.ConclusionsThe new ultrasound method of congestion diagnostics in the pulmonary circulation by the maximum and/or minimum diameter of the right superior pulmonary vein can be effectively applied in clinical practice in the same way as the well-known technique of congestion diagnostics in the systemic circulation by the diameter of the inferior vena cava in patients with the atrial fibrillation and chronic heart failure.

scholarly journals Usefulness of inferior vena cava ultrasonography in outpatients with chronic heart failure

2018 ◽  
Vol 41 (4) ◽  
pp. 510-517 ◽  
Author(s):  
Jose Curbelo ◽  
Maria Aguilera ◽  
Pablo Rodriguez-Cortes ◽  
Paloma Gil-Martinez ◽  
Carmen Suarez Fernandez
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Vena Cava

Inferior Vena Cava Dilatation Predicts Mortality and Worsening Renal Function in Patients With Chronic Heart Failure

2015 ◽  
Vol 21 (8) ◽  
pp. S70 ◽  
Author(s):  
Abdul Hafidz Muhammad Iqbal ◽  
Bayan Soujeri ◽  
Hawkey Sean ◽  
Daniel Levin ◽  
Muhammad Zaid Iskandar ◽  
...  
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Chronic Heart Failure ◽  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Vena Cava ◽  
Worsening Renal Function

Mitral and Aortic Atresia Associated with Hypoplastic Right Lung, Crossover Segment of Right Lower Lobe, and Anomalous Scimitar-like Right Pulmonary Venous Connection with Inferior Vena Cava: Clinical, Angiocardiographic, and Autopsy Findings in a Rare Case

1998 ◽  
Vol 1 (5) ◽  
pp. 413-419 ◽  
Author(s):  
Ulrike Bartram ◽  
Stella Van Praagh ◽  
John F. Keane ◽  
Peter Lang ◽  
Mary E. van der Velde ◽  
...  
Keyword(s):  
Inferior Vena Cava ◽  
Pulmonary Vein ◽  
Inferior Vena ◽  
Pulmonary Veins ◽  
Left Lung ◽  
Vena Cava ◽  
Lower Lobe ◽  
Aortic Atresia ◽  
Collateral Vein ◽  
The Right

A newborn female infant was found to have a unique and previously unreported group of anomalies: ( 1) mitral and aortic atresia with a highly obstructive atrial septum; ( 2) hypoplasia of the right lung with a crossover segment involving the right lower lobe; ( 3) normally connected pulmonary veins, two from the left lung and one from the right; and ( 4) a large anomalous branch of the right pulmonary vein of scimitar configuration that anastomosed with the normally connected right pulmonary vein and with the inferior vena cava (IVC). The scimitar vein appeared obstructed at its junction with the right pulmonary vein and at its junction with the inferior vena cava within the hepatic parenchyma. To our knowledge, this is the first report of a scimitar-like vein coexisting with mitral and aortic atresia and connecting both with the right pulmonary vein and with the inferior vena cava. The highly obstructed left atrium was partially decompressed by retrograde blood flow via the normally connected right pulmonary vein to the anomalous scimitar venous pathway and thence to the inferior vena cava via a pulmonary-to-IVC collateral vein.

Prevention of Contrast-Induced Nephropathy by Inferior Vena Cava Ultrasonography-Guided Hydration in Chronic Heart Failure Patients

Cardiology ◽  
2021 ◽  
pp. 1-8
Author(s):  
Yuanming Yan ◽  
Mingfang Ye ◽  
Xianfeng Dong ◽  
Qin Chen ◽  
Huashan Hong ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Coronary Angiography ◽  
Inferior Vena Cava ◽  
Inferior Vena ◽  
Vena Cava ◽  
Control Group ◽  
Contrast Induced Nephropathy ◽  
Heart Failure Patients ◽  
Significant Difference

<b><i>Introduction:</i></b> Contrast-induced nephropathy (CIN) is a common complication resulting from the administration of contrast media. This study was designed to determine whether inferior vena cava (IVC) ultrasonography (IVCU)-guided hydration can reduce the risk of CIN in chronic heart failure patients undergoing coronary angiography or coronary angiography with percutaneous coronary intervention compared with standard hydration. <b><i>Methods:</i></b> This prospective clinical trial enrolled 207 chronic heart failure patients from February 2016 to November 2017, who were randomly assigned to either the IVCU-guided hydration group (<i>n</i> = 104) or the routine hydration group (<i>n</i> = 103). In the IVCU-guided group, the hydration infusion rate was set according to the IVC diameter determined by IVCU, while the control group received intravenous infusion of 0.9% saline at 0.5 mL/(kg·h). Serum Cr was measured before and 48–72 h after the procedure. All patients were followed up for 18 months. The incidence of nephropathy and major adverse cardiovascular or cerebrovascular events (MACCEs) was also compared between the 2 groups. <b><i>Results:</i></b> Statistically significant difference between the 2 groups regarding the occurrence of CIN was observed (12.5 vs. 29.1%, <i>p</i> = 0.004). The hydration volume of the IVCU-guided group was significantly higher than that of the routine group (<i>p</i> &#x3c; 0.001). In addition, patients receiving IVCU-guided hydration had significantly lower risk of developing MACCEs than patients in the control group during the 18-month follow-up (14.4 vs. 27.2%, <i>p</i> = 0.027). <b><i>Conclusion:</i></b> Our findings support that IVCU-guided hydration is superior to standard hydration in prevention of CIN and may substantially reduce longtime composite major adverse events.

Sign in / Sign up

Export Citation Format

Share Document